1. Home
  2. Research
  3. Research Groups
  4. Neurodegenerative diseases: therapy development

Neurodegenerative diseases: therapy development

Search for publications

Only original articles, editorials, guidelines.

  • Sagredo O, García-Arencibia M, de Lago E, Finetti S, Decio A, Fernández-Ruiz J.

    Cannabinoids and neuroprotection in basal ganglia disorders

    MOLECULAR NEUROBIOLOGY . 36(1): 82-91. Number of citations: 71

    [doi:10.1007/s12035-007-0004-3]

  • García-Arencibia M, González S, de Lago E, Ramos JA, Mechoulam R, Fernández-Ruiz J.

    Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties

    BRAIN RESEARCH . 1134(1): 162-170. Number of citations: 206

    [doi:10.1016/j.brainres.2006.11.063]

  • GÓMEZ CAÑAS, MARÍA, FERNÁNDEZ RUIZ, JOSÉ JAVIER.

    Synthesis and pharmacological evaluation of new (E)- and (Z)-3-aryl-4-styryl-1H-pyrazoles as potential cannabinoid ligands

    Arkivoc . 2010: 226-247.

    [doi:10.3998/ark.5550190.0011.a19]

  • Gonzalo-Consuegra C, Santos-García I, García-Toscano L, Martín-Baquero R, Rodríguez-Cueto C, Wittwer MB, Dzygiel P, Grether U, de Lago E, Fernández-Ruiz J.

    Involvement of CB(1) and CB(2) receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice.

    BIOMEDICINE & PHARMACOTHERAPY . 174: 116473-116473.

    [doi:10.1016/j.biopha.2024.116473]